Series date: 
07/01/2023 - 7:00am CDT to 06/30/2024 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  

Frequency

Weekly

Series Director

Terzah Horton, MD, PhD

Series Co-Director

Johnathan Flanagan, PhD

Target Audience and Needs

Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and clinical and research nurses in pediatric hematology-oncology need to receive regular updates on the latest clinical trial data concerning hematological-oncological disorders in children and advances in targeted therapies for these disorders. Learners also need regular reviews of the ethical and legal issues surrounding end-of-life care and of the evolving practice standards for follow-up care for long-term survivors of hematological-oncological disorders. The series aims to increase the knowledge and skills of the learners to enhance the quality of healthcare, increase patient safety, and improve patient outcomes.

Educational Methods

Educational methods will include lectures, case presentations, literature review, and panel discussion.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss new research data in pediatric hematologic and oncologic disorders and incorporate these data into clinical and research activities.
  • Identify ethical and legal issues pertaining to clinical care and research activities pertaining to pediatric hematology and oncology.
  • Evaluate drug development for pediatric malignancies and blood disorders.
  • Analyze and interpret the significance of long-term survivorship issues related to pediatric malignancies and hematologic disorders.
  • Recognize how quality improvement cycles can be applied to a specific and common clinical problem.
  • Develop strategies to improve communication between clinical teams in different medical settings.
Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 
Lashon Cooper
lbcoope1@texaschildrens.org
832-822-1322
Series location: 
Texas Children's Hospital
6621 Fannin Street
Houston, TX 77030
United States
See map: Google Maps

Sessions

Session Date
The Shifting Paradigms of Treatment for Hemophilia 10/05/2023 - 8:00am to 9:00am CDT
Shared Decision-Making for Hemophilia 10/12/2023 - 8:00am to 9:00am CDT
Genetic, Epigenetic, and Functional Heterogeneity in Brain Tumors 11/09/2023 - 8:00am to 9:00am CST
Tackling Rare: Overcoming Challenges in Histiocytosis 11/30/2023 - 8:00am to 9:00am CST
Opportunities to Improve Health, Quality of Life, and Survival for Adolescents and Young Adults with Cancer 12/07/2023 - 8:00am to 9:00am CST
Improving Cell Therapy for Solid Tumors by Targeting the Inhibitory Tumor Microenvironment 12/14/2023 - 8:00am to 9:00am CST
Opportunities for Optimizing Care in Pediatric Thyroid Cancer 01/04/2024 - 8:00am to 9:00am CST
Pediatric Acute Myeloid Leukemia: Recent Progress and New Approaches 01/11/2024 - 8:00am to 9:00am CST
Deciphering the Cell Intrinsic and Extrinsic Mechanisms of ZFTA Fusion Driven Ependymoma 02/08/2024 - 8:00am to 9:00am CST
Using Proteomics to Select Therapy in Acute Myelogenous Leukemia 04/11/2024 - 8:00am to 9:00am CDT

Pages